12:00 AM
 | 
Jun 05, 2006
 |  BC Week In Review  |  Clinical News  |  Regulatory

Orapred ODT prednisolone regulatory update

FDA approved Orapred ODT prednisolone to treat pediatric asthma and reduce inflammation from various inflammatory conditions. Alliant Pharmaceuticals Inc. (Alpharetta, Ga.),...

Read the full 81 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >